CEBPD and breast carcinoma: Based on the analysis of scRNA-seq and bulk RNA-seq data, we built and validated a cancer fibroblast-related risk signature consisting of five genes (BGN, LUM, CCL19, CEBPD, and ID3) that may be utilized as an independent prognostic indicator for breast cancer patients.